The Strategy for Strengthening the Vaccine Development and Production System
The cabinet approved the "Strategy for Strengthening the Vaccine Development and Production System" on June 1, 2021, as part of the long-term national strategy to produce and develop vaccines domestically. The Ministry of Economy, Trade and Industry will therefore implement the following initiatives:
- The project of Developing Biopharmaceutical Manufacturing Sites to Strengthen Vaccine Production
- Strengthening Program for Pharmaceutical Startup Ecosystem
-
The Strategy for Strengthening the Vaccine Development and Production System(Summary)
-
The Strategy for Strengthening the Vaccine Development and Production System
The project of Developing Biopharmaceutical Manufacturing Sites to Strengthen Vaccine Production
In preparation for the further emergence of new variant or pandemic, the government aims to develop dual-use facility that manufactures biopharmaceuticals to meet corporate needs during the normal times and switches to vaccine manufacturing in the event of an emergency. This initiative will provide support for the equipment used for formulation and filling that are essential for vaccine manufacturing as well as facility to produce parts and material required for pharmaceutical manufacturing.
Strengthening Program for Pharmaceutical Startup Ecosystem
In order to alleviate the supply shortage of large-scale development funds, this program supports pharmaceutical startup companies on their development aimed at practical application, especially focusing on those engaged in preclinical development, Phase 1 clinical trial or Phase 2 clinical trial. To qualify for this program, funding is required from certified venture capitals specializing in drug development and providing the hands-on commercialization support.
Contacts
Bio-Industry Division
Commerce and Service Industry Policy Group
TEL:03-3501-8625 (Direct)
FAX:03-3501-0197
Download(To Adobe site)Last updated:2023-03-20